Clinical Trials
- Mental Health & Behavioral Research
Ketamine for Adolescent Suicidality
- Ages13 years - 17 years
- GenderBoth
- Mental Health & Behavioral Research, Alzheimer's
Ketamine for the Treatment of Depression in Parkinson's Disease
- Ages40 years - 70 years
- GenderBoth
- Brain, Spinal Cord & Nervous System, Mental Health & Behavioral Research
Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy (PTSD)
- Ages21 years - 70 years
- GenderBoth
- Mental Health & Behavioral Research
AMPA Receptor Components of the Anti-Depressant Ketamine Response
- Ages18 years - 65 years
- GenderBoth
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
- Mental Health & Behavioral Research
Safety, feasibility, and tolerability of psilocybin treatment for individuals with functional impairment related to mood, anxiety, trauma and/or addiction symptoms: An open-label proof-of-concept study